Rehablines: a Further Use Databank to (re)Use Routine Clinical Data for Scientific Research in Rehabilitation of People With Physical Disabilities and/or Chronic Diseases (Rehablines)

Within the Center of Rehabilitation multidisciplinary treatment is provided to people with various physical disabilities and/or chronic diseases. During and in the context of this treatment, a lot of data is routinely collected. Rehablines is initiated to re-use this routine clinical data in a database for future scientific research. Rehablines aims to: - Efficiently conduct high quality scientific research aimed at patient characteristics, underlying disease processes, and treatment effects; - Provide insight into (short and long-term) treatment effects and efficiency of these rehabilitation treatments; - Personalize treatment by comparing data from the individual patient with data from a large number of patients with similar characteristics from Rehablines.

Study Overview

• Status: Recruiting
• Conditions: Rehabilitation

• Study Type: Observational
• Enrollment (Estimated): 20000

Contacts and Locations

• Study Contact: Name: K van Kammen, PhD, PhD; Phone Number: +3150 - 361 6160; Email: rehablines@umcg.nl

Study Locations

• Netherlands
  • Groningen, Netherlands, 9700 RB
    • Recruiting
    • Center for Rehabilitation of the University Medical Center Groningen
    • Contact: K van Kammen, PhD; Phone Number: +3150 - 361 6160; Email: rehablines@umcg.nl

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Child; Adult; Older Adult
• Accepts Healthy Volunteers: No

• Sampling Method: Non-Probability Sample

Study Population

In the UMCG-CvR rehabilitation care is provided to patients with a variety of physical disabilities and/or chronic diseases. Provided types of rehabilitation include for instance neurorehabilitation, orthopedic rehabilitation, oncology rehabilitation, pain rehabilitation, pediatric rehabilitation and rehabilitation in chronic illnesses, e.g. heart, lung, diabetes, thoracic and transplant rehabilitation. All patients who are starting their treatment in our facility are invited to participate in Rehablines.

Description

Inclusion Criteria:

• all participants receiving care at the Center for Rehabilitation of the University Medical Center Groningen

Exclusion Criteria:

• n.a.

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Clinical data	Rehablines is a unique databank that purely re-uses clinical data for research. All data that is collected during the treatment of our patients can be re-used with patient consent.	Timepoint 1: pre-treatment. Timepoint 2: throughout study completion (on average 12 weeks). Timepoint 3: up to 1 year follow up

Collaborators and Investigators

• Sponsor: University Medical Center Groningen

Study record dates

Study Major Dates

• Study Start (Actual): August 1, 2023
• Primary Completion (Estimated): January 1, 2044
• Study Completion (Estimated): January 1, 2044

Study Registration Dates

• First Submitted: December 9, 2024
• First Submitted That Met QC Criteria: December 24, 2024
• First Posted (Actual): March 25, 2025

Study Record Updates

• Last Update Posted (Actual): March 25, 2025
• Last Update Submitted That Met QC Criteria: December 24, 2024
• Last Verified: December 1, 2024

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Pathologic Processes; Disease Attributes; Chronic Disease
• Other Study ID Numbers: UMCG RR number: 16881

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: UNDECIDED

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No